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Primary cardiac angiosarcoma is a rare cardiac tumor. The initial clinical course is often asymptomatic, and metastatic disease
is present in a majority of aﬀected patients at diagnosis. We present a patient who presented with a hemorrhagic pericardial
eﬀusion. No malignant cells were evident on cytological examination. He subsequently developed membranoproliferative
glomerulonephritis requiring hemodialysis. Metastatic cardiac angiosarcoma was diagnosed 5 months later. To our knowledge,
this is the ﬁrst reported case of paraneoplastic membranoproliferative glomerulopathy associated with cardiac angiosarcoma.
1.Introduction
The occurrence of paraneoplastic glomerulopathies in pa-
tients with cancer is well recognized [1]. We report a patient
with cardiac angiosarcoma who initially presented with a
pericardial eﬀusion and paraneoplastic glomerulopathy.
2.CaseReport
A 79-year-old Caucasian male presented with gradually
worsening shortness of breath and fatigue. A chest X-ray
revealed pulmonary congestion and cardiomegaly. Lab tests
revealed normal kidney function. A transthoracic echocar-
diogram revealed a large pericardial eﬀusion with features
of cardiac tamponade. Hemorrhagic ﬂuid was obtained at
pericardiocentesis, and around 400 milliliters were drained.
Cytology was negative for malignant cells. Bacterial cultures
grew Staphylococcus epidermidis. Though the clinical picture
was not suggestive of bacterial pericarditis, he was treated
with intravenous vancomycin for 4 weeks.
A month later the patient developed shortness of breath
and progressive pedal edema. Laboratory studies revealed
a serum creatinine of 8.8mg/dL. Spot urine protein to
creatinine ratio was 3.1. He was found to have low comple-
ment C3 and normal C4 levels. Serum ANA, ANCA, hep-
atitis serology, and serum and urine protein electrophore-
sis were negative. A repeat transthoracic echocardiogram
revealed a small pericardial eﬀusion and normal cardiac
function. A renal biopsy was performed. Light microscopy
revealed hypercellular glomeruli with some prominence of
mesangial matrix (Figure 1). Immunoﬂuorescence staining
demonstrated granular glomerular basement membrane and
variable mesangial staining with IgG, IgM, C3, C1q, kappa,
and lambda. Tubular basement membranes and arterioles
stained positive with C3. Electron microscopy demonstrated
scattered small electron dense immune deposits within the
mesangium and located primarily below the glomerular
basement membrane reﬂection. There were no features sug-
gestive of postinfectious glomerulonephritis or vancomycin-
induced renal injury. Though C1q staining is not typical, the
combined light, immunoﬂuorescence, and electron micro-
scopic ﬁndings were felt to be consistent with a diagnosis
of type 1 membranoproliferative glomerulonephritis. The
patient was started on thrice weekly hemodialysis. Five
months later, the patient developed gradually worsening
diﬀuse abdominal and lower back pain. An abdominal
and pelvis CT noted multiple hepatic and spinal lesions2 Case Reports in Medicine
Figure 1: H & E stain of renal biopsy: Light micrograph suggestive
of membranoproliferative glomerulonephritis showing hypercellu-
lar glomeruli with prominence of mesangial matrix.
Figure 2: Computed tomography scan of the chest showing the
right atrial mass and pericardial eﬀusion.
suspicious for metastasis. In addition, a heterogeneously
enhancing mass with features of central necrosis was present
in the right atrioventricular groove invading the wall of the
right atrium (Figure 2). An ultrasound-guided needle core
biopsy of a hepatic lesion revealed an angiosarcoma (Figure
3). This was presumed to be of cardiac origin based on the
imaging features. Patient opted for palliative treatment with
hospice care.
3. Discussion
Primary tumors of the heart are rare with the incidence
varying from 0.001% to 0.03% [2]. Further malignant
tumors account for just 25% of the primary cardiac tumors
[3]. Angiosarcomas account for around 33% of all primary
malignantcardiactumors.Theyarehoweverexceedinglyrare
with an incidence of only 0.0001% in autopsy series [4].
Primary cardiac angiosarcomas rarely cause symptoms
until late in the clinical course. Most of the symptoms are
due to either pericardial eﬀusion with or without cardiac
tamponade, venal caval obstruction, arrhythmias, or related
to metastases to other organs [5]. In fact, 66% to 89%
of patients have metastatic disease at presentation [6].
Common sites of metastases include the pericardium, lungs,
liver, mediastinal lymph nodes, and bone [5].
Figure 3: H & E stain of the liver biopsy—angiosarcoma with
hyperchromatic spindle cells.
Paraneoplastic glomerulopathies are rare manifestations
of neoplastic disease. Nephrotic syndrome is the most com-
mon presentation of these paraneoplastic glomerulopathies.
Diﬀerent glomerular diseases are associated with diﬀerent
neoplasia,suchasmembranousnephropathyinpatientswith
solid tumors and minimal changes disease which is strongly
associated with Hodgkin’s lymphoma [7]. Sarcomas have
rarely been associated with paraneoplastic glomerulopathy.
In a recent review of the literature by Bacchetta et al. [1],
6 cases of sarcoma with paraneoplastic glomerulonephritis
wereidentiﬁed[1].Pathologyinthreeofthemwasconsistent
with membranous nephropathy where as there was one
case each associated with minimal change disease, focal and
segmental glomerulosclerosis, and with mesangiocapillary
glomerulonephritis. To our knowledge, no cases of glomeru-
lopathy associated with cardiac angiosarcoma have been
reported in the literature.
Atemporalrelationshipbetweentheglomerulopathyand
the cancer is suspected when kidney dysfunction develops
6 months before or after the diagnosis of malignancy [8].
The syndrome often precedes discovery of tumor by several
months. This is illustrated by a study which showed protein-
uria preceded or occurred at the same time as cancer in 80%
of patients [9]. Although the pathological mechanism for
paraneoplastic glomerulopathy remains unknown, tumor-
associated immune complexes and deposit nephritogenicity
havebeenimplicatedinglomerularinjuryandovertneoplas-
tic renal disease [10].
Inourpatient,membranoproliferativeglomerulonephri-
tis developed almost ﬁve months before the diagnosis of
metastatic angiosarcoma. The initial diﬀerential diagnosis
of the glomerulopathy included vancomycin-induced or
postinfectious etiologies. There were, however, no features
of drug toxicity on kidney biopsy and no evidence of
supratherapeutic levels during drug monitoring. There was
no convincing evidence of a postinfectious etiology either.
Though the patient was treated as presumptive bacterial
pericarditis, the clinical presentation was not consistent
with the diagnosis. The coagulase negative staphylococcus
may have been a contaminant and was not isolated in any
other body ﬂuid. In addition, bacteria rarely cause hem-
orrhagic pericardial eﬀusion; iatrogenesis and malignancyCase Reports in Medicine 3
are much more common causes in the Western hemisphere
[11]. Staphylococcus epidermidis infection of ventriculoatrial
shunts can cause membranoproliferative glomerulonephritis
(shunt nephritis). Similar renal eﬀects have been noted in
patients with infected central venous catheters [12]. Nephri-
tis typically manifests prior to the start of antimicrobial
therapy. The lack of a shunt or indwelling catheter in our
patient and the appearance of kidney disease a month
after eﬀective treatment of presumed infection make this
diagnosis less likely. Investigations for all other causes of
MPGN were negative, and the patient was diagnosed to have
idiopathic MPGN.
Cytology of the hemorrhagic pericardial ﬂuid at initial
presentation was negative for malignant cells. This is not
unusual in the case of cardiac angiosarcoma [13, 14]. The
initial echocardiogram did not reveal any mass in the right
atrium. The tumor was probably too small to be detected
using transthoracic echocardiography, and similar instances
have been described in the literature [14, 15]. Though this
approach has not been validated in clinical studies, it may
be reasonable to obtain magnetic resonance imaging of the
heart and pericardium in cases of hemorrhagic pericardial
eﬀusion with no obvious pathology. After pericardiocentesis,
the patient did not develop recurrence of signiﬁcant pericar-
dial eﬀusion as one would expect in the case of an untreated
malignancy. A similar phenomenon has been described
in at least two previously reported cases of angiosarcoma
[14, 16]. Though angiosarcoma was diagnosed 5 months
after the detection of glomerulonephritis, it was probably
already present at the onset of kidney disease and was thus
considered the most likely etiology.
4. Conclusion
Our case report represents a patient with paraneoplastic
membranoproliferative glomerulonephritis as an early pre-
senting feature of cardiac angiosarcoma. It also illustrates the
diﬃculties faced by clinicians in diagnosing primary cardiac
angiosarcoma. Pericardial cytology may be negative, and the
pericardial eﬀusion may not recur after the initial episode.
Transthoracicechocardiographymaynotbesensitiveenough
todiagnosethesetumorsatpresentation.Finally,malignancy
should be ruled out before classifying glomerulonephritis as
idiopathic.
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